Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With Neuroblastoma

Exclusion Criteria

• •ALT/AST \> 3 ULN, or TBIL \> 1.5 ULN;
• •Have experienced congestive heart failure, arrhythmia, peripheral arteriovenous thrombosis requiring medication treatment within one year prior to enrollment, or have experienced myocardial infarction or cerebral infarction within three months prior to enrollment;
• •Suffering from thromboembolic diseases;
• •Other situations that are not suitable for inclusion in the study determined by researchers.